--- title: "Accelerating Cancer Research: Microplate Reader-Based Viability Analysis for Rapid Drug Candidate Identification in Patient-Derived Organoids" description: Join LABX and Molecular Devices as we discuss Patient-Derived Organoids image: https://go.labx.com/hubfs/LabManager/Webinars/Registration%20Pages/2024-21-5%20Accelerating%20Cancer%20Research%20Microplate%20Reader-Based%20Viability%20Analysis/OnDemand-1200x600.jpg --- ![OnDemand-990x200](https://go.labx.com/hs-fs/hubfs/LabManager/Webinars/Registration%20Pages/2024-21-5%20Accelerating%20Cancer%20Research%20Microplate%20Reader-Based%20Viability%20Analysis/OnDemand-990x200.jpg?width=990&height=200&name=OnDemand-990x200.jpg "OnDemand-990x200") If you have already registered, please check your email for the webinar link. # Accelerating Cancer Research: Microplate Reader-Based Viability Analysis for Rapid Drug Candidate Identification in Patient-Derived Organoids Patient-derived organoids offer researchers biologically relevant models for cancer research, providing greater insights into candidate drug treatments for individualized treatment. Here, we demonstrate methods for analyzing organoid viability that allow for rapid identification of effective drug candidates and can be combined with further downstream image analysis. Using colorectal cancer organoid lines derived from patient tissues, organoid number and overall morphologies were assessed by label-free transmitted light imaging acquired and analyzed on ImageXpress Micro Confocal High-Content Imaging System and Image Acquisition and Analysis Software. The response of organoids to compounds after five days of compound treatment was assayed using the CellTiter-Glo® 3D Cell Viability Assay (Promega), with results detected using a SpectraMax® i3x Multi-Mode Microplate Reader and data analyzed using a preconfigured protocol in SoftMax Software. Such use of label-free imaging and plate-reader-based viability analysis serve as preliminary approaches to identifying potential drugs with measurable effects on treated organoids. | ![OnDemand Video Icon](https://go.labx.com/hs-fs/hubfs/LabManager/Webinars/Registration%20Pages/OnDemand%20Video%20Icon.png?width=50&height=50&name=OnDemand%20Video%20Icon.png)   | **Available On Demand** | | --- | --- | |   |   |   Speakers ![Andrew Dix.jpg](https://go.labx.com/hubfs/LabManager/Webinars/Registration%20Pages/2024-21-5%20Accelerating%20Cancer%20Research%20Microplate%20Reader-Based%20Viability%20Analysis/Angelin%20Lim%20headshot%20100x100.jpg "Andrew Dix, PhD") **Dr. Angeline Lim** Sr. Applications Scientist Molecular Devices ![Andrew Dix.jpg](https://go.labx.com/hubfs/LabManager/Webinars/Registration%20Pages/2024-21-5%20Accelerating%20Cancer%20Research%20Microplate%20Reader-Based%20Viability%20Analysis/Krystal%20Belmonte%20Headshot%20100x100.jpeg "Andrew Dix, PhD") **Dr. Krystal Courtney Belmonte** BioResearch Field Applications Scientist Molecular Devices ![](https://go.labx.com/hs-fs/hubfs/LabManager/Webinars/Registration%20Pages/2024-5-9%20From%20Lab%20to%20Table%20Advancing%20Global%20Food%20Sustainability%20with%20Molecular%20Devices/Molecular%20Devices_Logo_Color.jpg?width=350&name=Molecular%20Devices_Logo_Color.jpg) # Register Now! You must have Javascript and Cookies enabled to access this webcast. ## LabXneeds the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our [Privacy Policy](https://www.labx.com/v2/aboutlabx/faq_popup.cfm?faqid=1058).   ![](https://go.labx.com/hs-fs/hubfs/Images/LX/Logos-and-Buttons/LabX%20Logo%20New_white.png?width=180&name=LabX%20Logo%20New_white.png)   LabX.com c/o LabX Media Group 334 King Street, Unit 2, Midland, Ontario, Canada, L4R 3M8 Toll-Free: 888.781.0328 | Phone: 705.528.6888 Email: [privacy@labx.com](mailto:privacy@labx.com) Copyright © 1995-2023 [LabX.com](http://www.labx.com/) All Rights Reserved. Designated trademarks and brands are the property of their respective owners. Use of this website constitutes acceptance of the [LabX User Agreement](https://www.labx.com/cms/terms-conditions).